22 - 23 February 2022 | DECHEMA-Haus, Frankfurt am Main

 

In view of the current developments regarding the coronavirus, we unfortunately will postpone the event to spring time 2022.

 

In recent years, Advanced Therapy Medicinal Products (ATMP) have evolved into a promising and highly hoped-for medical approach to cure a broad spectrum of inherited and acquired human diseases, ranging from cancer to immunological disorders and rare diseases. However, the path from development to clinical application is not yet routine.

 

The conference will highlight the challenging field of gene and cell therapeutics.

 

Advances in development and manufacturing will be presented at ATMP 2022, as well as quality control methods and regulatory aspects:
The focus is on the path to safe and beneficial advanced therapies for the patient.

 

More information about registration, fees, program or venue.